Description: Proteins are important biomolecules, fulfilling tasks in every cell of your body and with a central role in health and disease. Dr. Harald Weinstabl and Dr. Will Farnaby lead collaboration at Boehringer Ingelheim and the University of Dundee working on PROTACs, a new class of molecules with the potential to selectively target and destroy disease-causing proteins. Drs. Weinstabl and Farnaby’s interdisciplinary research team has achieved significant tumor growth inhibition in mice, and this molecule is freely available to other researchers.
